Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1 (DM1)

Key facts

Sponsor

Hanns Lochmuller

Intervention

Music and movement education(behavioral)

Enrollment

13 enrolled

Eligibility

6-18 years · All sexes

Timeline

2025 – 2026

Study locations (1)

• Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada

Collaborators

University of Ottawa

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Other trials for Myotonic dystrophy

Additional recruiting or active studies for the same condition.

• RECRUITINGPHASE3NCT07486934
  Efficacy, Safety, and Tolerability of DYNE-101 in Participants With Myotonic Dystrophy Type 1
  Dyne Therapeutics
• RECRUITINGPHASE2NCT07220603
  An Open-Label Extension Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1 (FREEDOM-OLE)
  PepGen Inc
• ACTIVE NOT RECRUITINGNCT07493525
  Fall Frequency and Factors Affecting Dynamic Balance in Patients With Myotonic Dystrophy Type 1
  Antalya Training and Research Hospital
• RECRUITINGNCT06747884
  Trial Readiness and Endpoint Assessment in Pediatric Myotonic Dystrophy Extension
  Virginia Commonwealth University
• RECRUITINGNCT07385443
  The Spanish National Registry for Myotonic Dystrophy Type 1
  Fundació Institut Germans Trias i Pujol
• RECRUITINGNCT07362875
  Development of Quantitative Muscle Imaging as a Biomarker of Disease Endpoints in Myotonic Dystrophy
  Wake Forest University Health Sciences
• RECRUITINGPHASE2NCT06667453
  A Clinical Study of PGN-EDODM1 in People With Myotonic Dystrophy Type 1
  PepGen Inc
• RECRUITINGPHASE3NCT05532813
  Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)
  Assistance Publique - Hôpitaux de Paris

See all trials for Myotonic dystrophy →